Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa open-label multicenter study of UA007 for acute gouty arthritis flare
CTR20221512Phase 2Active
- Sponsor
- Jiaochen Biopharmaceutical
- Start
- Aug 2022
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of UA007 in gout, sponsored by Jiaochen Biopharmaceutical. Started Aug 2022; status: active.
02
Drugs
UA007
03
Conditions
gout
Beyond the preview
Go deeper on CTR20221512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221512.